Summary & Overview
HCPCS G9070: Small Cell Lung Cancer Disease Status/Staging
HCPCS Level II code G9070 denotes a disease-status or staging assessment for small cell lung cancer (including limited and combined small cell/non-small cell presentations) when the extent of disease is unknown, staging is in progress, or not listed. The code is designated for use within a Medicare-approved demonstration project, highlighting its role in structured data capture for oncology care and program evaluation. Nationally, such codes matter for tracking clinical staging workflows, program participation, and payment pathways tied to demonstration initiatives.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for G9070, typical sites of service, and implications for coding workflows in oncology settings. The publication outlines benchmarks and policy context where available, clarifies which data elements are present or absent in the input, and summarizes common operational considerations for staging-related oncology codes. The focus is on helping clinicians, coders, and policy analysts understand how G9070 fits into national coding practice and demonstration-project reporting rather than on specific payer reimbursement rates.
Billing Code Overview
HCPCS Level II code G9070 indicates oncology disease status assessment specifically for small cell lung cancer (including limited small cell and combined small cell/non-small cell). The code description covers situations where the extent of disease is unknown, staging is in progress, or staging is not listed, and its use is specified for a Medicare-approved demonstration project.
Service Type: Oncology — disease status/staging assessment
Typical Site of Service: Oncology clinic or hospital outpatient setting, where diagnostic staging and disease-status evaluations for lung cancer are performed.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 64-year-old patient with a history of tobacco use presents after imaging demonstrates a central lung mass and mediastinal lymphadenopathy. A thoracic oncologist is coordinating staging and disease-status assessment for suspected small cell lung cancer (SCLC). Diagnostic workup includes history and physical, contrast-enhanced CT of the chest and abdomen, PET-CT for metastatic survey, brain MRI for CNS staging, and possible endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to obtain pathologic confirmation. The clinical team documents disease status as limited-stage SCLC versus combined small cell/non-small cell histology; extent of disease remains uncertain while staging studies and pathology are in progress.
The service represented by G9070 is used for reporting oncology disease-status assessment specific to small cell lung cancer when extent of disease is unknown, staging is in progress, or the condition is not listed, within the context of a Medicare-approved demonstration project. Typical workflow: initial oncology clinic visit to order staging studies, coordination of multidisciplinary review (medical oncology, thoracic surgery, radiation oncology, radiology, and pathology), documentation of provisional staging and plan while awaiting pathology and additional imaging, then subsequent definitive staging and treatment planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no specific modifier applies to the service |
22 | Increased procedural services | Use when work required is substantially greater than typically required |
23 | Unusual anesthesia | Use when procedure is performed under general anesthesia because of patient condition |
52 | Reduced services | Use when service is partially reduced or not completed as planned |
53 | Discontinued procedure | Use when procedure is started but discontinued due to extenuating circumstances |
54 | Surgical care only | Use when only the surgical portion is billed by the surgeon |
55 | Postoperative management only | Use when only postoperative care is billed by the surgeon |
56 | Preoperative management only | Use when only preoperative care is billed by the surgeon |
62 | Two surgeons | Use when two surgeons work together as primary surgeons on the same procedure |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | Use when an advanced practice clinician performs assistant-at-surgery services |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207RC0000X | Thoracic Surgery | Surgeons performing diagnostic resections or mediastinal staging |
207L00000X | Radiation Oncology | Radiation oncologists involved in staging and treatment planning for limited-stage SCLC |
2084P0800X | Medical Oncology | Medical oncologists coordinating systemic therapy and staging |
363A00000X | Clinical Laboratory | Pathology and cytology services for tissue diagnosis |
208D00000X | Pulmonary Disease | Pulmonologists performing bronchoscopy or EBUS for tissue sampling |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Common code for primary lung malignancy when site is not precisely documented during initial staging |
C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung | Used when tumor location is identified; guides surgical and radiation planning |
C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct | Representative metastatic site evaluated during staging for spread |
C79.31 | Secondary malignant neoplasm of brain | Brain metastases are assessed with MRI during staging workup |
Z85.118 | Personal history of other malignant neoplasm of bronchus and lung | Relevant for surveillance and distinguishing new primaries from recurrence |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
31622 | Bronchoscopy, rigid or flexible, with diagnostic transbronchial lung biopsy(s), single lobe | Performed to obtain tissue for histologic confirmation when bronchoscopy is indicated during staging |
31628 | Bronchoscopy with endobronchial ultrasound (EBUS) with transbronchial needle aspiration | Commonly used to sample mediastinal and hilar lymph nodes for staging SCLC |
71260 | Computed tomography, thorax; with contrast material(s) | Cross-sectional imaging used to evaluate primary tumor size, nodal involvement, and thoracic extent of disease |
78816 | Positron emission tomography (PET) imaging, whole body, metabolic evaluation | PET-CT employed to detect extrathoracic metastatic disease during staging |
70553 | Magnetic resonance (MR) imaging, brain, without and with contrast | Brain MRI used to assess for central nervous system metastases as part of staging |